Survey to Specify SGLT2 Inhibitor Choice in T2DM Management
OBJECTIVE: There are no major head-to-head comparative studies till date to compare the differences in glycemic efficacy, safety, or cardio-renal effects within SGLT2 inhibitors. This survey was conducted to understand the different parameters that clinicians identify while choosing an SGLT2 inhibit...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Via Medica
2022-10-01
|
| Edice: | Clinical Diabetology |
| Témata: | |
| On-line přístup: | https://journals.viamedica.pl/clinical_diabetology/article/view/87411 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|